The following medical device manufacturer and biotech mergers occurred in the past two months.
Supply Chain
In a span of two days, Minneapolis-based Medtronic announced plans to acquire two European companies.
The global market of electrodes for medical devices is expected to be valued at $1.45 billion in 2019, growing at a compound annual growth rate of 11.7 percent, according to a Transparency Market Research report.
Louisville, Colo.-based GHX, a healthcare supply chain technology company, reports saving $5 billion in supply chain savings for the North American healthcare market over the past five years.
Dublin, Ireland-based Covidien has acquired Irvine, Calif.-based Reverse Medical Corp.
Roche, a Swiss pharmaceutical company, plans to acquire Brisbane, Calif.-based InterMune, a biotech firm, for $8.3 billion, according to a Wall Street Journal report.
After the IRS released a report showing revenue from the Medical Device Tax was below projections, Sen. Dan Coats (R-Ind.) has started a new push to repeal the controversial tax, according to a report by The Hill.
Having a clear direction is one of the most important, and sometimes challenging, duties of a new supply chain leader, writes Luis Martinez, director of member services at Dallas-based MD Buyline.
Cost efficiency is becoming a new focus for payers as they strive to remain financially afloat in the healthcare reform landscape.
Healthmark Industries has announced they are now offering a new product in their storage product line, Magnetic Label Holders. Magnetic Label Holders are a secure method for displaying pertinent information on nearly any cart or trolley. Made of tough polyethylene…